Cargando…

Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy

Membrane remodeling is required for dynamic cellular processes such as cell division, polarization, and motility. BAR domain proteins and dynamins are key molecules in membrane remodeling that work together for membrane deformation and fission. In striated muscles, sarcolemmal invaginations termed T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujise, Kenshiro, Okubo, Mariko, Abe, Tadashi, Yamada, Hiroshi, Nishino, Ichizo, Noguchi, Satoru, Takei, Kohji, Takeda, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949082/ https://www.ncbi.nlm.nih.gov/pubmed/33187981 http://dx.doi.org/10.1074/jbc.RA120.015184

Ejemplares similares

Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants
por: Fujise, Kenshiro, et al.
Publicado: (2022)

Structural insights into the centronuclear myopathy-associated functions of BIN1 and dynamin 2
por: Hohendahl, Annika, et al.
Publicado: (2016)

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2017)

Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin
por: Muñoz, Xènia Massana, et al.
Publicado: (2020)

MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy
por: Giraud, Quentin, et al.
Publicado: (2023)

Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy
por: Fraysse, Bodvaël, et al.
Publicado: (2016)

Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy
por: Gómez-Oca, Raquel, et al.
Publicado: (2022)

Mutations in BIN1 Associated with Centronuclear Myopathy Disrupt Membrane Remodeling by Affecting Protein Density and Oligomerization
por: Wu, Tingting, et al.
Publicado: (2014)

Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008)

N-WASP is required for Amphiphysin-2/BIN1-dependent nuclear positioning and triad organization in skeletal muscle and is involved in the pathophysiology of centronuclear myopathy
por: Falcone, Sestina, et al.
Publicado: (2014)

Phosphorylation of cortactin by cyclin-dependent kinase 5 modulates actin bundling by the dynamin 1-cortactin ring-like complex and formation of filopodia and lamellipodia in NG108-15 glioma-derived cells
por: Abe, Tadashi, et al.
Publicado: (2018)

Phosphorylation of cortactin by cyclin-dependent kinase 5 modulates actin bundling by the dynamin 1-cortactin ring-like complex and formation of filopodia and lamellipodia in NG108-15 glioma-derived cells
por: Abe, Tadashi, et al.
Publicado: (2020)

Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells
por: González-Jamett, Arlek M., et al.
Publicado: (2017)

BIN1 modulation in vivo rescues dynamin-related myopathy
por: Lionello, Valentina Maria, et al.
Publicado: (2022)

Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model
por: Fongy, Anaïs, et al.
Publicado: (2019)

Pathogenic Mechanisms in Centronuclear Myopathies
por: Jungbluth, Heinz, et al.
Publicado: (2014)

Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy
por: Böhm, Johann, et al.
Publicado: (2013)

Mild Functional Differences of Dynamin 2 Mutations Associated to Centronuclear Myopathy and Charcot-Marie-Tooth Peripheral Neuropathy
por: Koutsopoulos, Olga S., et al.
Publicado: (2011)

Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort
por: Catteruccia, Michela, et al.
Publicado: (2013)

A case of de novo dynamin 2 (DNM2)-related centronuclear myopathy with electrical but not clinical myotonia
por: Huang, Xiao, et al.
Publicado: (2020)

Correction: Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy
por: Böhm, Johann, et al.
Publicado: (2013)

Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2022)

Gain-of-Function Dynamin-2 Mutations Linked to Centronuclear Myopathy Impair Ca(2+)-Induced Exocytosis in Human Myoblasts
por: Bayonés, Lucas, et al.
Publicado: (2022)

Actin bundling by dynamin 2 and cortactin is implicated in cell migration by stabilizing filopodia in human non-small cell lung carcinoma cells
por: Yamada, Hiroshi, et al.
Publicado: (2016)

Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation
por: Böhm, Johann, et al.
Publicado: (2010)

Autosomal Dominant Centronuclear Myopathy with Unique Clinical Presentations
por: Lee, Jee-Young, et al.
Publicado: (2007)

Suspected Congenital Centronuclear Myopathy in an Arabian‐cross Foal
por: Polle, F., et al.
Publicado: (2014)

Novel SPEG variant cause centronuclear myopathy in China
por: Tang, Jia, et al.
Publicado: (2019)

Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands
por: Reumers, Stacha F. I., et al.
Publicado: (2021)

Phenotypic Spectrum of DNM2-Related Centronuclear Myopathy
por: Hayes, Leslie Hotchkiss, et al.
Publicado: (2022)

Three novel MTM1 pathogenic variants identified in Japanese patients with X‐linked myotubular myopathy
por: Nishikawa, Atsuko, et al.
Publicado: (2019)

Centronuclear myopathies under attack: A plethora of therapeutic targets
por: Tasfaout, Hichem, et al.
Publicado: (2018)

A Possible Case of Centronuclear Myopathy: A Case Report
por: Castillo-Ferrán, Narjara, et al.
Publicado: (2023)

Dynamic clustering of dynamin-amphiphysin helices regulates membrane constriction and fission coupled with GTP hydrolysis
por: Takeda, Tetsuya, et al.
Publicado: (2018)

Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
por: Fajardo, Val A., et al.
Publicado: (2015)

DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy
por: Abath, Osorio, et al.
Publicado: (2015)

Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Gómez-Oca, Raquel, et al.
Publicado: (2021)

Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy
por: Espinosa, Karla G., et al.
Publicado: (2022)

Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy
por: Park, Young-Eun, et al.
Publicado: (2014)

Phosphatase-Dead Myotubularin Ameliorates X-Linked Centronuclear Myopathy Phenotypes in Mice
por: Amoasii, Leonela, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6stirsqrq0po8qiq4hbfbd7ep6